During the past decade, National Center for Cancer Care & Research (NCCCR) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Center for Cancer Care & Research (NCCCR)" are "Essential Thrombocythemia" (2 trials), "Primary Myelofibrosis, Fibrotic Stage" (2 trials), "Primary Myelofibrosis, Prefibrotic Stage" (2 trials), "Chronic Myeloid Leukemia - Chronic Phase" (1 trials) and "Osteoporosis" (1 trials). Many other conditions were trialed in "National Center for Cancer Care & Research (NCCCR)" in a lesser frequency.

Most popular intervention types in "National Center for Cancer Care & Research (NCCCR)" are "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Diagnostic (18F-FLT PET/CT)" (2 trials), "Dasatinib 100 MG [Sprycel]" (1 trials), "Denosumab 60 MG/ML Prefilled Syringe" (1 trials), "Nilotinib 150mg oral capsule [Tasigna]" (1 trials) and "Zoledronic Acid 5Mg/Bag 100Ml Inj" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Center for Cancer Care & Research (NCCCR)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "National Center for Cancer Care & Research (NCCCR)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Center for Cancer Care & Research (NCCCR), undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Center for Cancer Care & Research (NCCCR), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".